Current status and perspectives of chimeric antigen receptor modified T cells for cancer treatment

Chimeric antigen receptor (CAR) is a recombinant immunoreceptor combining an antibody-derived targeting fragment with signaling domains capable of activating cells, which endows T cells with the ability to recognize tumor-associated surface antigens independent of the expression of major histocompat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhenguang, Guo, Yelei, Han, Weidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Higher Education Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712290/
https://www.ncbi.nlm.nih.gov/pubmed/28466386
http://dx.doi.org/10.1007/s13238-017-0400-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712290/
https://www.ncbi.nlm.nih.gov/pubmed/28466386
http://dx.doi.org/10.1007/s13238-017-0400-z

Ejemplares similares